MDx Highlights from the American Society of Clinical Oncology's 2012 Meeting
June 13, 2012
MDx Highlights from the American Society of Clinical Oncology's 2012 Meeting
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Clarient's Mammostrat to Enter Breast Cancer Recurrence Market as LDT by Fourth Quarter
July 14, 2010 / Pharmacogenomics Reporter - Agendia Hoping Fourth FDA Clearance for MammaPrint Convinces Payors
December 23, 2009 / Pharmacogenomics Reporter - St. Gallen's Recommendations May Impact Adoption of Leading Breast Cancer Genetic Tests
July 8, 2009 / Pharmacogenomics Reporter - CMS Stance on Reimbursement of Multi-Analyte Algorithm Assays Raises Industry Concerns
September 19, 2012 / Pharmacogenomics Reporter - Deal with NewBridge Allows Genomic Health to Expand Oncotype DX into Africa, Middle East
August 13, 2012 / GenomeWeb Daily News